Jobs: The WHSC helps make Emory the largest employer in DeKalb County and the second largest employer in metro Atlanta.
Economic impact:With $3.8 billion in operating expenditures in fiscal year 2016, the WHSC’s annual economic impact on metro Atlanta is estimated at $7.5 billion.
Construction: Emory Healthcare (EHC) is constructing a 450,000-square-foot tower addition to Emory University Hospital (EUH), scheduled to open in 2017, and is also making extensive renovations to the existing EUH building as well as EHC outpatient facilities. EHC also is partnering with the Atlanta Hawks to build the 90,000-square-foot Emory Sports Medicine Complex in Executive Park, which will include a state-of-the-art practice center and training facility and the Emory Sports Medicine Center.
Clinical trials: Emory currently has 17,240 participants enrolled in 1,800 clinical trials of investigational drugs, devices, and procedures, more trials than any other institution in the state.
Technology transfer: Over the past 32 years, Emory has launched 46 products into the marketplace and helped create 82 start-up companies (46 in Georgia) in drug discovery, medical devices, diagnostics, and software. Nine out of 10 U.S. HIV/AIDS patients on lifesaving therapy take drugs discovered at Emory. Emory investigators have filed patent applications in more than 90 countries, including 2,917 in the U.S. and have been issued 1,758 patents in this country. The 32 patents Emory was granted last year addressed treatment options for HIV, hepatitis C, diabetes, and various cancers.
Research dollars: The WHSC received $540.1 million in sponsored research funds in fiscal year 2016, bringing Emory’s total for the year to $574.6 million. These awards include funds for a consortium to develop vaccines and cure for HIV, drug development against emerging and manmade microbial threats, establishment of a national lab network to measure impact of environmental chemicals on children's health, development of better treatments for malaria, a vaccine against breast cancer, and many more.
Physician workforce: Emory’s medical school provides more than half of the residency training positions in Georgia; 54 of the medical school’s 104 residency programs are the only such programs in the state. Such programs provide a critical recruiting base for Georgia’s physician workforce.
Investment in education: The WHSC invested 24.9% of its tuition income in fiscal year 2016 in student financial aid, an amount totaling $26.4 million.
Vaccine testing and development: The Emory Vaccine Center is one of the largest academic vaccine centers in the world, with scientists working on vaccines for Ebola, AIDS, malaria, hepatitis C, influenza, tuberculosis, and other diseases. Emory’s Hope Clinic, which conducts clinical trials for promising vaccines, is part of the country’s premier networks for vaccine and prevention trials for infectious diseases, including globally emerging diseases like Ebola, Zika, and Chikungunya.
Charity care: Emory Healthcare provided $72.3 million in charity care in fiscal year 2016. Emory faculty also provided $27.1 million in uncompensated care in fiscal year 2016 at the publicly owned Grady Memorial Hospital. Via the Emory Medical Care Foundation, the Emory faculty practice plan at Grady, faculty invested all payments received for patient care at Grady ($46 million) to support Emory’s patient services at that facility. Emory also is a preeminent provider of specialty care to indigent children in Georgia. The WHSC's community contributions to support patient care, education, and research totaled almost $400 million in fiscal year 2016.
HIV/AIDS: Emory provides medical direction of Grady Health System’s Ponce de Leon Center, one of the largest, most comprehensive AIDS treatment centers in the country. Emory is also a primary site in the nation’s premier NIH-funded AIDS clinical trials network and has had a national NIH-designated Center for AIDS Research since 1998.
Fighting cancer: Winship investigators have led or contributed to the pivotal clinical trials testing nearly 75% of all anti-cancer drugs approved by the FDA since 2011. Winship played a key role in development of four new FDA-approved drugs to treat myeloma. Emory scientists also discovered the role of the PD-1 molecule in immune response, paving the way for development of new drugs being used against lung cancer and melanoma.
Transplantation: The Emory Transplant Center is the fifth busiest solid organ transplant center in the nation and the most comprehensive in the state. Emory's liver transplant program ranks second nationally and first in Georgia in patient outcomes. Emory researchers developed a new class of now FDA-approved immunosuppressant drugs for kidney transplant patients that are less toxic than drugs previously available.
Philanthropy: In fiscal year 2016, the WHSC was awarded more than $178 million in private support from individuals, foundations, and corporations representing alumni, patients and their families, and friends.
Quality of care: Emory Healthcare is the only system in Georgia that has three hospitals with Magnet designation, recognizing excellence in nursing care.
Emory University's Woodruff Health Sciences Center is working to pioneer new ways to prevent and treat disease, prepare the next generation to save and improve lives, provide the highest-quality clinical care possible, and serve the community.